RECEPTOS INC. / CELGENE CORPORATION / Public / Acquisition / £4639m

Synopsis

Sale of Receptos, a clinical-stage biopharmaceutical company, to Celgene.

Principals

Receptos Inc.

Celgene Corporation

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

target

5445

Deals

£ 3,505.44 B

Total Value

centerview partners

HQ - New York

financial advisors

target

554

Deals

£ 1,917.17 B

Total Value